Evidence-Based Pharmacotherapies for Alcohol Use Disorder: Clinical Pearls
Evidence-Based Pharmacotherapies for Alcohol Use Disorder: Clinical Pearls
About this item
Full title
Author / Creator
Publisher
England: Elsevier, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier, Inc
Subjects
More information
Scope and Contents
Contents
Pathologic alcohol use affects more than 2 billion people and accounts for nearly 6% of all deaths worldwide. There are three medications approved for the treatment of alcohol use disorder by the US Food and Drug Administration (FDA): disulfiram, naltrexone (oral and long-acting injectable), and acamprosate. Of growing interest is the use of antico...
Alternative Titles
Full title
Evidence-Based Pharmacotherapies for Alcohol Use Disorder: Clinical Pearls
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2440495891
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2440495891
Other Identifiers
ISSN
0025-6196
E-ISSN
1942-5546
DOI
10.1016/j.mayocp.2020.01.030
